Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Comparison Neuromuscular Blockade Monitors

NCT: NCT05006807 · COMPLETED

NCT IDNCT05006807
StatusCOMPLETED
Start Date2022-02-01
Completion2024-12-01
SponsorUniversity of Washington (OTHER)
First posted
Last updated

Brief Summary

The overall objective of this research is to evaluate different laboratory-built and commercially available sensors used to measure the effects of neuromuscular blocking drugs on neuromuscular function during surgery, by measuring evoked thumb twitch response to ulnar nerve stimulation (also known as "twitch monitoring"). The specific aim is to compare mechanomyography, which is the "gold standard" laboratory measurement to assess neuromuscular blockade, to the sensors used in commercially available neuromuscular blockade monitors, such as acceleromyography and electromyography. The study endpoints are the train-of-four count (TOFC), the ratio of the height of the 4th twitch to the height of the 1st twitch (train-of-four ratio, TOFR), and the post tetanic count (PTC). The mechanomyography devices have been constructed in our laboratory and are not commercially available.

Frequently Asked Questions

What is Comparison Neuromuscular Blockade Monitors?

Comparison Neuromuscular Blockade Monitors is a clinical trial registered under NCT05006807. Current status: COMPLETED.

What is the status of NCT05006807?

The current status of NCT05006807 (Comparison Neuromuscular Blockade Monitors) is: COMPLETED.

When did Comparison Neuromuscular Blockade Monitors start?

Comparison Neuromuscular Blockade Monitors started on 2022-02-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.